Table 1. Patient characteristics.
VLA-4 Low/CD38 Low | VLA-4 High/CD38 High | VLA-4 Low/CD38 High | VLA-4 High/CD38 Low | Total | |
Nā=ā | 83 | 30 | 13 | 18 | 144 |
Characteristics | Percent of patients (%) | ||||
Sex | |||||
Female | 45 | 43 | 31 | 44 | 43 |
Male | 55 | 57 | 69 | 56 | 57 |
Rai stage | |||||
0 | 47 | 23 | 46 | 22 | 39 |
I-II | 48 | 53 | 46 | 56 | 50 |
III-IV | 5 | 23 | 8 | 22 | 11 |
Treatment status | |||||
Chemonaive | 70 | 40 | 54 | 39 | 58 |
Treated | 30 | 60 | 46 | 61 | 42 |
Risk parameters | |||||
IgVH UMT | 10 | 62 | 70 | 54 | 31 |
FISH High-risk | 6 | 31 | 27 | 27 | 15 |
ZAP-70 High-risk | 21 | 75 | 60 | 40 | 38 |
IgVH UMT, unmutated IgVH; FISH High-risk, either del17p, del11q or tri12;